drugset / Trial / NCT07115121

Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients

NCT07115121

Completed 40 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

Literature search has shows that both ferric carboxymaltose and iron sucrose complex are equally effective. Unfortunately, local data addressing this issue is scarce. To get further local data, the current study was planned with the objective to compare the mean change in hemoglobin with ferric carboxymaltose and IV iron sources in anemic antenatal patients in our local population.

Timeline

Start
2025-02-02
Primary completion
2025-07-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 1000 mg Intravenous
Subject Iron sucrose Unknown 200 mg Intravenous

Indications